Nirogacestat
- Generic Name
- Nirogacestat
- Drug Type
- Small Molecule
- Chemical Formula
- C27H41F2N5O
- CAS Number
- 1290543-63-3
- Unique Ingredient Identifier
- QZ62892OFJ
Overview
Nirogacestat has been used in trials studying the treatment of Breast Cancer, HIV Infection, Desmoid Tumors, Advanced Solid Tumors, and Aggressive Fibromatosis, among others.
Background
Nirogacestat has been used in trials studying the treatment of Breast Cancer, HIV Infection, Desmoid Tumors, Advanced Solid Tumors, and Aggressive Fibromatosis, among others.
Indication
No indication information available.
Associated Conditions
No associated conditions information available.
Clinical Trials
FDA Approved Products
OGSIVEO
Manufacturer:SpringWorks Therapeutics, Inc.
Route:ORAL
Strength:50 mg in 1 1
Approved: 2023/12/15
NDC:82448-050
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath